Verastem, Inc.·4

Sep 24, 4:30 PM ET

Calkins Daniel 4

4 · Verastem, Inc. · Filed Sep 24, 2025

Insider Transaction Report

Form 4
Period: 2025-09-22
Calkins Daniel
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2025-09-24$9.23/sh25$231109,838 total
  • Sale

    Common Stock

    2025-09-22$9.08/sh57$518109,863 total
Footnotes (1)
  • [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Documents

1 file
  • 4
    tm2526868-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT